AI assistant
Sending…
Nykode Therapeutics ASA — Share Issue/Capital Change 2021
Dec 3, 2021
3695_dirs_2021-12-03_545cf908-39b8-4a94-9c06-15ff83a63ad3.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Subscription of warrants
Subscription of warrants
Oslo, Norway, December 3, 2021 - Reference is made to the Extraordinary General Meeting (EGM) in Vaccibody AS held on November 30, 2021, where an extension of the expiry date for certain warrants held by primary insiders Agnete B. Fredriksen and Anders Tuv was resolved. The extension will be made through the termination of existing warrants and the issuance of the same number of new warrants with the new expiry date. Agnete B. Fredriksen and Anders Tuv have today subscribed for the warrants on the terms resolved by the EGM.
Please see further details in attached document.
More from Nykode Therapeutics ASA
Interim / Quarterly Report
2026
May 27
Earnings Release
2026
May 27
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30